Graypoint LLC Zoetis Inc. Transaction History

Graypoint LLC

$1.52 Billion
Q3 2024

A detailed history of Graypoint LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Graypoint LLC holds 6,098 shares of ZTS stock, worth $1.08 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

6,098

Previous 6,132 0.55%

Holding current value

$1.08 Million

Previous $1.06 Million 12.04%

% of portfolio

0.08%

Previous 0.08%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$172.58 - $196.48 $5,867 - $6,680	-34 Reduced 0.55%	6,098 $1.19 Million
Q2 2024 Jul 31, 2024	SELL	$145.54 - $178.83 $51,812 - $63,663	-356 Reduced 5.49%	6,132 $1.06 Million
Q1 2024 May 02, 2024	BUY	$165.67 - $199.94 $214,873 - $259,322	1,297 Added 24.99%	6,488 $1.1 Million
Q4 2023 Jan 29, 2024	BUY	$151.44 - $200.09 $47,097 - $62,227	311 Added 6.37%	5,191 $1.02 Million
Q3 2023 Oct 26, 2023	BUY	$167.14 - $192.77 $67,023 - $77,300	401 Added 8.95%	4,880 $849,000
Q2 2023 Jul 21, 2023	BUY	$160.94 - $186.23 $163,515 - $189,209	1,016 Added 29.34%	4,479 $771,000
Q1 2023 May 02, 2023	BUY	$145.48 - $175.02 $165,847 - $199,522	1,140 Added 49.07%	3,463 $576,000
Q4 2022 Jan 31, 2023	SELL	$131.14 - $157.47 $25,047 - $30,076	-191 Reduced 7.6%	2,323 $340,000
Q3 2022 Oct 31, 2022	BUY	$148.29 - $182.55 $75,924 - $93,465	512 Added 25.57%	2,514 $373,000
Q2 2022 Aug 01, 2022	BUY	$155.97 - $200.09 $14,817 - $19,008	95 Added 4.98%	2,002 $344,000
Q1 2022 Apr 19, 2022	SELL	$181.39 - $234.03 $94,322 - $121,695	-520 Reduced 21.43%	1,907 $360,000
Q4 2021 Jan 31, 2022	BUY	$193.69 - $247.03 $190,203 - $242,583	982 Added 67.96%	2,427 $592,000
Q3 2021 Nov 09, 2021	BUY	$189.29 - $209.69 $273,524 - $303,002	1,445 New	1,445 $281,000

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.

Account